Cabaletta Bio
CABA
CABA
61 hedge funds and large institutions have $211M invested in Cabaletta Bio in 2021 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 19 increasing their positions, 15 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
7.7% more ownership
Funds ownership: 76.4% → 84.1% (+7.7%)
3% less funds holding
Funds holding: 63 → 61 (-2)
17% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 12
Holders
61
Holding in Top 10
2
Calls
$1.41M
Puts
$445K
Top Buyers
| 1 | +$10.9M | |
| 2 | +$6.35M | |
| 3 | +$4.25M | |
| 4 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$3.68M |
| 5 |
O
OrbiMed
New York
|
+$3.68M |
Top Sellers
| 1 | -$10.6M | |
| 2 | -$7.6M | |
| 3 | -$395K | |
| 4 |
Morgan Stanley
New York
|
-$356K |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
-$309K |